Literature DB >> 8973550

Heparin-decasaccharides impair the catabolism of chylomicrons.

O Chevreuil1, M Hultin, P Ostergaard, T Olivecrona.   

Abstract

On intravenous injection to rats, decasaccharides gave rise to a short-lived peak of lipoprotein lipase (LPL) activity, whereas octa- and hexasaccharides caused only marginal increases. In isolated hearts perfused by a single pass, decasaccharides released LPL more efficiently than conventional heparin on a mass basis. Octa- and hexasaccharides were much less efficient. Similar results were obtained for hepatic lipase, which was studied both in vivo and by liver perfusion. In the intact rat, the heparin fragments themselves disappeared rapidly from the circulating blood. The decay of hepatic lipase activity after the early peak roughly paralleled the decay of decasaccharide concentration, but for LPL the decay was faster, presumably because the liver extracted this lipase from plasma. To assess the lipase activities remaining in contact with blood a large dose of conventional heparin was injected at a series of times after the decasaccharides. LPL was decreased by 40% after 1 h. At that time, the LPL activity that could be released from isolated hearts by single-pass perfusion with heparin for 2 min ("functional LPL') was decreased by 75%. Chylomicrons labelled in vivo with [14C]oleic acid (primarily in triacylglycerols, providing a tracer for lipolysis) and [3H]retinol (primarily in ester form, providing a tracer for the particles) were injected intravenously to explore the effects of the LPL depletion on lipoprotein metabolism. Triacylglycerol lipolysis and particle clearance was markedly delayed from 30 min to 2 h after injection of decasaccharides. After 1 h the fractional catabolic rate was only one-third of the control value and the catabolism of chylomicron triacylglycerols by perfused hearts was delayed to a similar extent. Thus injection of decasaccharides leads to accelerated turnover of LPL with loss of functional LPL from extrahepatic tissues. This in turn leads to a period of delayed lipolysis and removal of chylomicron particles.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8973550      PMCID: PMC1217949          DOI: 10.1042/bj3200437

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  26 in total

1.  Effect of protamine on lipoprotein lipase and hepatic lipase in rats.

Authors:  M Hultin; G Olivecrona; T Olivecrona
Journal:  Biochem J       Date:  1994-12-15       Impact factor: 3.857

2.  Pharmacokinetics of tinzaparin (Logiparin)--a low molecular weight heparin--after single and repeated intravenous administration in rats.

Authors:  P B Johansen; S N Rasmussen; P B Ostergaard
Journal:  Thromb Res       Date:  1994-08-15       Impact factor: 3.944

3.  Release of lipoprotein lipase to plasma by triacylglycerol emulsions. Comparison to the effect of heparin.

Authors:  M Hultin; G Bengtsson-Olivecrona; T Olivecrona
Journal:  Biochim Biophys Acta       Date:  1992-04-08

4.  Lipoprotein lipase. Molecular model based on the pancreatic lipase x-ray structure: consequences for heparin binding and catalysis.

Authors:  H van Tilbeurgh; A Roussel; J M Lalouel; C Cambillau
Journal:  J Biol Chem       Date:  1994-02-11       Impact factor: 5.157

5.  Continuous intravenous heparin administration in humans causes a decrease in serum lipolytic activity and accumulation of chylomicrons in circulation.

Authors:  M Weintraub; T Rassin; S Eisenberg; Y Ringel; I Grosskopf; A Iaina; G Charach; M Liron; A Rubinstein
Journal:  J Lipid Res       Date:  1994-02       Impact factor: 5.922

6.  Isolation and characterization of hexasaccharides derived from heparin. Analysis by HPLC and elucidation of structure by 1H NMR.

Authors:  A Larnkjaer; S H Hansen; P B Ostergaard
Journal:  Carbohydr Res       Date:  1995-01-03       Impact factor: 2.104

7.  Depletion of lipoprotein lipase after heparin administration.

Authors:  O Chevreuil; M Hultin; P Ostergaard; T Olivecrona
Journal:  Arterioscler Thromb       Date:  1993-10

8.  Biphasic effects of low-molecular-weight and conventional heparins on chylomicron clearance in rats.

Authors:  O Chevreuil; M Hultin; P Ostergaard; T Olivecrona
Journal:  Arterioscler Thromb       Date:  1993-10

9.  Release of lipoprotein lipase from cardiac myocytes by low-molecular weight heparin.

Authors:  J E Braun; D L Severson
Journal:  Lipids       Date:  1993-01       Impact factor: 1.880

10.  Oligosaccharide sequences of endothelial cell surface heparan sulfate proteoglycan with affinity for lipoprotein lipase.

Authors:  N Parthasarathy; I J Goldberg; P Sivaram; B Mulloy; D M Flory; W D Wagner
Journal:  J Biol Chem       Date:  1994-09-02       Impact factor: 5.157

View more
  2 in total

1.  Lipoprotein lipase responds similarly to tinzaparin as to conventional heparin during hemodialysis.

Authors:  Dana Mahmood; Maria Grubbström; Lennart D I Lundberg; Gunilla Olivecrona; Thomas Olivecrona; Bernd G Stegmayr
Journal:  BMC Nephrol       Date:  2010-12-06       Impact factor: 2.388

2.  Lipoprotein lipase in hemodialysis patients: indications that low molecular weight heparin depletes functional stores, despite low plasma levels of the enzyme.

Authors:  Birgit Näsström; Bernd Stegmayr; Gunilla Olivecrona; Thomas Olivecrona
Journal:  BMC Nephrol       Date:  2004-11-03       Impact factor: 2.388

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.